| |
Full list of projects 1999
|
Title
of project
MEETING OF THE
EXPERTS COMMITTEE OF THE EUROPE AGAINST
CANCER PROGRAMME OF THE EUROPEAN
COMMISSION,
20-21 OCTOBER 1998
|
|
ORGANISATION
Name: EUROPEAN CANCER PREVENTION ORGANIZATION, ECP
(UK) HEADQUATERS, LADY SOBELL, GASTROINTESTINAL
UNIT
Address: Wexham Park
Hospital, Slough
UK-SL 2 4HL BERKS
Telephone: +44/1256/882 564
Fax: +44/1256/880 416
Contact person: Dr. MICHAEL HILL
|
PARTNER
COUNTRIES
A,B,D,DK,E,EL,F,FIN,I,IRL,L,NL,P,S,UK |
| START
OF PROJECT: 20/10/98 |
END
OF PROJECT: 1/4/99 |
| COUNTRY
OF ORIGIN: UK |
REFERENCE:
99/CAN/36011 |
| OBJECTIVE
AND CONTENTS OF THE PROJECT
Organisation
of the Meeting of the Experts Committee of the
Europe against Cancer Programme of the European
Commission to be held on 20-21 October 1998.
|
 |
|
Title
of project
DIFFERENCES IN THE
SURVIVAL OF COLORECTAL
CANCER PATIENTS
BETWEEN EUROPE AND USA
|
|
ORGANISATION
Name: ISTITUTO NAZIONALE PER LO STUDIO E LA CURA
DEI TUMORI
Address: Via Venezian, 1
I-20133 MILANO
Telephone: +39/02/2390460
Fax: +39/02/2390762
Contact person: Dr. GEMMA GATTA
|
PARTNER
COUNTRIES
E,F,FIN,I,NL,UK |
| START
OF PROJECT: 1/2/99 |
END
OF PROJECT: 31/3/00 |
| COUNTRY
OF ORIGIN: I |
REFERENCE:
99/CAN/36616 |
| OBJECTIVE
AND CONTENTS OF THE PROJECT
There are
large survival differences between American and
European colorectal cancer patients. In the US
5-year relative survival for colorectal cancer was
58% (SEER program, white, 1983-85), while in
Europe it was 45% for colon and 41% for rectum
(EUROCARE, 1983-85). Differences were particularly
evident among the oldest patients, aged 65 or
more.
This
project's aim is to describe and interpret these
survival differences in terms of patterns of care
(stage, diagnostic determinants of stage and
therapy) using the same statistical approaches and
criteria for the selection of patients. Focusing
on differences between age groups and comparing
short term (6 months) and long-term (up to 10
years) survival, this study will help in
understanding whether survival differences can be
due to stage, treatment or to early diagnosis
without later death (early detection bias). If
these differences are not an artifact they can
indicate the need of a major effort in order to
improve the management of colorectal cancer
patients in Europe.
|
|
|
Title
of project
EUROPEAN NETWORK OF
CANCER REGISTRIES (ENCR)
|
|
ORGANISATION
Name: INTERNATIONAL AGENCY FOR RESEARCH ON
CANCER/WORLD HEALTH ORGANIZATION (WHO)
Address: 150 cours Albert
Thomas
F-69372 LYON CEDEX 08
Telephone: +33/4/72.73.84.85
Fax: +33/4/72.73.83.19
Contact person: Dr. DONALD MAXWELL PARKIN
|
PARTNER
COUNTRIES
A,B,D,DK,E,EL,F,FIN,I,IRL,L,NL,P,S,UK |
| START
OF PROJECT: 1/4/99 |
END
OF PROJECT: 1/7/00 |
| COUNTRY
OF ORIGIN: F |
REFERENCE:
99/CAN/36621 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
Objectives
* to increase the quality and comparability of
data on cancer incidence and outcome in countries
of the EU;
* to extend the availability of such data by
encouraging population-based cancer registration;
* within the EU;
* to promote the use of cancer registry data in
Europe;
* to provide an information system for monitoring
cancer oncurrence (incidence, mortality, survival
prevalence) in the countries of the EU, including
regular dissemination of information;
* to provide a review of time trends of cancer
incidence and mortality in the countries of the
EU;
* to provide training, consultantship and
information exchange activities. |
|
|
Title
of project
AUTOMATED CHILDHOOD
CANCER REGISTRATION SYSTEM (ACCIS)
|
|
ORGANISATION
Name: INTERNATIONAL AGENCY FOR RESEARCH ON
CANCER/WORLD HEALTH ORGANIZATION (WHO)
Address: 150 cours Albert
Thomas
F-69372 LYON CEDEX 08
Telephone: +33/4/72.73.84.85
Fax: +33/4/72.73.83.19
Contact person: Dr. DONALD MAXWELL PARKIN
|
PARTNER
COUNTRIES
A,D,DK,E,F,FIN,I,IRL,NL,P,S,UK |
| START
OF PROJECT: 1/1/99 |
END
OF PROJECT: 31/12/00 |
| COUNTRY
OF ORIGIN: F |
REFERENCE:
99/CAN/36622 |
| OBJECTIVE
AND CONTENTS OF THE PROJECT
1.
Construction of Automated Childhood Cancer
Information System (ACCIS) - a database containing
information on incidence, mortality, prevalence
and survival of childhood cancer patients in
Europe.
2.
Scientific exploitation of ACCIS and publication
of comparative studies of incidence, mortality,
survival and prevalence :
a) for distinct tumour types,
b) for countries and regions within Europe,
including comparison with data from outside
Europe.
3. Devising
means and rules of use of ACCIS for external users
on two levels : public and scientific.
4.
Development of automated procedure of regular
updates of ACCIS.
|
|
|
Title
of project
IMPACT
OF EARLY DETECTION ON INCIDENCE RATES
OF
FEMALE GENITAL CANCERS AND THE IMPORTANCE
OF ESTIMATING THE PREVALENCE OF
HYSTERECTOMIES
|
|
ORGANISATION
Name: UNIVERSITY OF BREMEN//BREMEN INSTITUTE FOR
PREVENTION RESEARCH AND SOCIAL MEDICINE (BIPS)
Address: Postfach 330440
D-28334 BREMEN
Telephone: +49.421.2187788
Fax: +49.421.2183684
Contact person: Prof. EBERHARD GREISER
|
PARTNER
COUNTRIES
D,NL,FIN,P,E,UK |
| START
OF PROJECT: 1/4/99 |
END
OF PROJECT: 30/3/00 |
| COUNTRY
OF ORIGIN: D |
REFERENCE:
99/CAN/36651 |
| OBJECTIVE
AND CONTENTS OF THE PROJECT
The aims of
the project \"Impact of early detection on
incidence rates of female genital cancers and the
importance of estimating the prevalence of
hysterectomies\" are the correction of
incidence rates of uterine cancers by estimating
the prevalence of hysterectomies in the population
and the presentation and discussion of the results
at a symposium in February which will bring
together experts from Cancer Registries from all
EC member states. The conventional method used to
report age and site-specific cancer-incidence
rates uses the total number of new cases during a
given period of time as the numerator, and the
total population \"at risk\" as the
denominator. The population at risk is given as
the annual average by age-group and sex for the
period under consideration (1,2). However,
consideration must be given to the numbers of
women who have had a hysterectomy for a
non-malignant condition, because such women are
not at risk of developing cancer of the cervix or
corpus uteri. Therefore, corpus and cervical
canceer incidence rates may be biased, if
hysterectomized women have not been removed from
the population at risk. In Germany and in other
European countries, incidence rates of cancer of
the corpus and cervix uteri are not systematically
corrected because the prevalence of hysterectomy
is n ot known or considered to be too low to be
significant.
|
|
|
Title
of project
PREVENTION OF
MELANOMA AND NON-MELANOCYTIC SKIN CANCERS.
DEVELOPMENT OF A NEW METHOD FOR HIGH RISK
GROUPS DETECTION :
MELANINS DETERMINATION
IN HAIR SAMPLES
|
|
ORGANISATION
Name: PIEDMONT CANCER REGISTRY, UNIT OF CANCER
EPIDEMIOLOGY, AZIENDA SANITARIA LOCALE 1 TORINO
Address: Via San Francesco
da Paola 31
I- 10123 TORINO
Telephone: +39/011/8127375
Fax: +39/011/5662005
Contact person: Dr. ROBERTO ZANETTI
|
PARTNER
COUNTRIES
I,F,E,DK,D,UK,P |
| START
OF PROJECT: 1/4/99 |
END
OF PROJECT: 30/9/00 |
| COUNTRY
OF ORIGIN: I |
REFERENCE:
99/CAN/36673 |
| OBJECTIVE
AND CONTENTS OF THE PROJECT
The aim of
the project is to further investigate the causes
of skin cancers (both melanoma and non-melanocytic
skin tumours) and to elaborate a test to identify
subjects at higher risk, test to be potentially
used to refine the indications of primary
prevention as well to define early diagnosis
schemes.
The results
of the pilot phase, which was financed as a
feasibility study by Europe Against Cancer in
1997-98, proved that the determination of the
molecular type of melanin on hair samples offers
new possibilities to define phenotypes at risk of
developing melanoma and skin carcinomas.
The pilot
phase showed that the method is feasible on a
population basis and that it can discriminate the
phenotypes better than the previous techniques of
visual examination could do. The present study
aims to assess the relationship between the typoe
of melanin (whether eu- or pheomelanin) and
different types of skin cancer.
The
objectives will be attained through a case-control
study, with three sets of cases (melanoma,
Squamous- and Basal-cell carcinoma) and a set of
controls recruited in 13 Centres in 8 European
countries.
Using such a
population basis allows both to examine a wider
range of skin phenotypes, and to realise a study
of considerable size (over 1,000 case on total)
within a short span of time.
|
|
|
Title
of project
- EURO-GLOBALINK -
TELECOMMUNICATION SUPPORT
FOR EUROPEAN
SMOKING PREVENTION ORGANISATIONS
|
|
ORGANISATION
Name: INTERNATIONAL UNION AGAINST CANCER
Address: 3, rue du Conseil Général
CH-1205 GENEVA
Telephone: +41/22/809 18 11
Fax: +41/22/809 18 10
Contact person: Mr. RUBEN ISRAEL
|
PARTNER
COUNTRIES
B,D,DK,E,EL,F,FIN,I,IRL,L,NL,P,UK |
| START
OF PROJECT: 1/1/99 |
END
OF PROJECT: 1/3/00 |
| COUNTRY
OF ORIGIN: CH |
REFERENCE:
99/CAN/36698 |
| OBJECTIVE
AND CONTENTS OF THE PROJECT
To develop
and operate GLOBALink, The International
Tobacco-Control Network. A communication service
with more than 850 Members covering all Europe :
- linking intergovernmental, national and
non-governmental organisations via a secure
information system and electronic-conferences,
increasing efficiency through improved
communication, multimedia and coordination
- supporting the communication infrastructure of
most the European Smoking Prevention Organizations
- providing instant access to an interactive
computer information service with an expanding
multimedia data base of reference and resource
materials, regular news bulletins and 'action
alerts.
|
|
|
Title
of project
EXPLAINING STOMACH
CANCER SURVIVAL DIFFERENCES
AMONG EUROPEAN
COUNTRIES
|
|
ORGANISATION
Name: ISTITUTO SUPERIORE DI SANITÀ
Address: 299, Viale Regina
Elena
I-00161 ROME
Telephone: +39/06/49902230
Fax: +39/06/49387069
Contact person: Dr. ARDUINO VERDECCHIA
|
PARTNER
COUNTRIES
A,D,DK,E,F,FIN,I,NL,S,UK |
| START
OF PROJECT: 1/2/99 |
END
OF PROJECT: 31/3/00 |
| COUNTRY
OF ORIGIN: I |
REFERENCE:
99/CAN/36720 |
| OBJECTIVE
AND CONTENTS OF THE PROJECT
To explain
which part of the variation in stomach cancer
patients survival among different countries is
attributable to a different pattern of incidence
cases by sub-site and histotype and which part to
different functionality of health care systems.
To correct
for sub-site and histotype stomach cancer survival
rates.
To obtain
net survival differences that need to be properly
explained by stage, diagnostic and therapeutic
factors by ad hoc studies.
To study the
expected impact of the declining trend in stomach
cancer incidence.
|
|
|
Title
of project
EUROPEAN PROSPECTIVE
INVESTIGATION INTO CANCER AND NUTRITION.
THE NORWEGIAN WOMEN AND CANCER COHORT
STUDY
|
|
ORGANISATION
Name: UNIVERSITY OF TROMSO, INSTITUTE OF COMMUNITY
MEDICINE
Address:
NO-9037 TROMSO
Telephone: +47/77644816
Fax: +47/77644831
Contact person: Prof. EILIV LUND
|
PARTNER
COUNTRIES
NL,F,I,E,EL,D,UK,S,DK |
| START
OF PROJECT: 1/3/99 |
END
OF PROJECT: 1/9/00 |
| COUNTRY
OF ORIGIN: NO |
REFERENCE:
99/CAN/36885 |
| OBJECTIVE
AND CONTENTS OF THE PROJECT
To collect
blood samples as part of the EPIC study from
10.000 women aged 40-45 years in Norway.
The women
constitutes a random sample of the Norwegian
population and has been informed about the purpose
of the study. They have given informed consent as
part of filling in an 8 pages questionnaire with 4
pages of dietary habits. The 24-hours recall is
implemented as part of the calibration in EPIC.
The inclusion of a biological bank in a subsample
will make the Norwegian \"Women and
Cancer\" study an equal member of the EPIC
study.
|
|
|
Title
of project
MULTICENTRIC CASE
CONTROL STUDY ON THE AETIOLOGY OF
LYMPHOMAS.
EPILYMPH
|
|
ORGANISATION
Name: CATALAN INSTITUTE OF ONCOLOGY
Address: Km 2.7/Gran Via
E-08907 L'HOSPITALET DE LLOBREGAT
Telephone: +34/93/2607812
Fax: +34/93/2607787
Contact person: Dr. SILVIA DE SANJOSE
|
PARTNER
COUNTRIES
E,F,I,IRL,D,FIN,NL |
| START
OF PROJECT: 1/1/99 |
END
OF PROJECT: 1/6/01 |
| COUNTRY
OF ORIGIN: E |
REFERENCE:
99/CAN/36965 |
| OBJECTIVE
AND CONTENTS OF THE PROJECT
To identify
the contribution fo Epstein-Barr virus (EBV),
Human Immunodeficiency virus (HIV), Hepatitis C
virus (HCV) and Herpes virus 8 (HHV-8) to the
occurence of lymphoid neoplasms in Europe.
|
|
|
Title
of project
CANCER SURVIVAL IN
EUROPEAN ELDERLY PATIENTS
AND ITS
CLINICAL, SOCIAL AND ECONOMIC DETERMINANTS
|
|
ORGANISATION
Name: NATIONAL CANCER INSTITUTE
Address: 10, Largo Rosanna
Benzi
I-16132 GENOA
Telephone: +39/10/5600961
Fax: +39/10/5600501
Contact person: Prof. MARINA VERCELLI
|
PARTNER
COUNTRIES
I,F,E,A,D,NL,UK,FIN,DK,S |
| START
OF PROJECT: 1/4/99 |
END
OF PROJECT: 1/10/00 |
| COUNTRY
OF ORIGIN: I |
REFERENCE:
99/CAN/37211 |
| OBJECTIVE
AND CONTENTS OF THE PROJECT
1. To
estimate relative survival rates in ederly
(>=65 yrs) cancer patients in the European
countries by age classes, gender and calendar
period. Analyses according to prognostic factors,
such as tumour stage, histology and anatomical
subsite, will be also performed only for those
registries collecting data detailed and reliable
enough for such a purpose. Particular attention
will be paid to the oldest old (>= 90yrs), an
age class often excluded from most of
epidemiological studies. Both major cancer sites
(all cancers combined, stomach, colon-rectum,
lung, breast, cervix, corpus-uteri, ovary,
bladder, prostate, non Hodgkin's lymphomas) and
older age typical ones (e.g. multiple myeloma,
lymphatic and myeloid leukaemias) will be selected
for the analyses.
2. To relate
these survival rates to availability and
functioning of health care systems, welfare state
(by means of social services), other
socio-economic factors (e.g. educational level,
financial resources by age, social environment)
and demographic indexes. Such informations,
regarding elderly populations across European
countries, will be standardised according to the
most common statistical indexes adopted by
EUROSTAT and by National Statistical Institutes.
They will be used to explain the observed
differences in survival between younger and older
patients and among different countries.
|
|
|
Title
of project
EUROPEAN PROSPECTIVE
INVESTIGATION
INTO CANCER AND NUTRITION
(EPIC)
|
|
ORGANISATION
Name: CENTRE INTERNATIONAL DE RECHERCHE SUR LE
CANCER
Address: 150 Cours Albert
Thomas
F-69372 LYON CEDEX 08
Telephone: +33/4/72.73.84.12
Fax: +33/4/72.73.83.42
Contact person: Dr. ELIO RIBOLI
|
PARTNER
COUNTRIES
F,E,I,UK,NL,D,EL,S,DK |
| START
OF PROJECT: |
END
OF PROJECT: |
| COUNTRY
OF ORIGIN: F |
REFERENCE:
99/CAN/37689 |
| OBJECTIVE
AND CONTENTS OF THE PROJECT
The aim of
the EPIC study is to investigate the role of
dietary habits, nutritional characteristics and
lifestyle in determining the risk of cancer and
chronic diseases.
While our
current knowledge on diet and cancer is sufficient
to make some broad recommendations, which are
included in the Europe Against Cancer Guidelines
for cancer prevention, many important questions
remain unanswered on the diet and cancer link,
such as : * which compounds in vegetables and
fruits protect against cancer,
* the role of meat and fat in the etiology of
colorectal, breast and prostate cancer,
* the possible protection from fish,
* the role of specific dairy products and types of
fat,
* the effect of overweight, type of obesity and
physical activity in the etiology of various
cancers.
EPIC has major strenghts
wich make it a project so far unique in the world.
The main activities planned
by the Unit of Nutrition and Cancer at IARC (in
charge of coordination) and by the EPIC
collaborating centres are :
* Follow-up of the EPIC cohorts,
* Measurement of biomarkers of diet in the EPIC
cohorts,
* Statistical analyses to describe diet and
lifestyle in European populations using the
centralized database for all EPIC study subjects,
* Study of risk of cancer of the breast, lung,
colorectum and stomach in relation to diet and
lifestyle,
* Preparation of standardized food composition
tables.
|
|
|
Title
of project
ICAWEB - INFO CANCER
ON THE WEB
|
|
|
ORGANISATION
Name: EUROPEAN MEDICAL ASSOCIATION
Address: 12, Place de Jamblinne de Meux
B-1030 BRUXELLES
Telephone: +32/2 734 29 80
Fax: +32/2 734 21 35
Contact person: Dr. DOMINIQUE PARDOEN
|
PARTNER
COUNTRIES A,B,D,DK,E,EL,F,FIN,I,IRL,L,NL,S,UK
|
|
START OF
PROJECT: 1/3/99
|
END OF PROJECT:
1/3/00
|
|
COUNTRY OF
ORIGIN: B
|
REFERENCE:
99/CAN/36702
|
|
OBJECTIVE AND
CONTENTS OF THE PROJECT
This project
aims to improve the knowledge on cancer disease
among the broad public and enables it to grasp
scientific problems in an easy and simplified way.
It also focuses on information on prevention
issues and healthy behaviours to adopt and gives
an overview of examples of good practice where
treatments are carried out. Another important
target of the project is represented by General
Practitioners (GPs) seen as the interface between
patients and specialists. In fact, GPs are among
the firsts to share the problem with persons
affected by cancer disease and they have the
responsibility of helping them to choose the most
suitable specialised centres.
The project
consists in a comprehensive Web-site promoted by
the European Medical Association in co-operation
with European Cancer Association, representing the
needs of the network of patients, as well as with
Hospital Cancer Institutes. The site is structured
in three main parts : a multilanguage introduction
on how to get the information and use the software
tools, a second and third part with material
developed explicity for the broad public and GPs.
An innovative
approach will be taken into account, which is
represented by the following aspects :
a) validation
activity permanently carried out by a Scientific
Committee formed by specialists appointed by
Cancer Associations/Institutes. This will assure
the high quality of the information put on the
Web-site. The Committee will also improve the
level of awareness among the broad public by
drawing up specific reports (also published on the
Web) which will give to people an effective tool
to understand these specific topics;
b)
Multilanguage and multicultural sensitivity
carried out through permanent assessment;
c) A wide range
of information designed for helping
decision-making and improve critical knowledge on
cancer related problems. This material will
include : a database on the pathologies with clear
explanations and ease of terminology to allow
understanding among non-professionals, a code on
preventional behaviours in different areas of
pathologies as well as on healthy life-styles to
adopt, a comprehensive and updated list on
training courses for all pathologies concerned for
medical doctors, a database of oncological centres
as well as of the specialists working there, press
review, information on the annual campaign within
Europe Against Cancer Programme, relevant
documents issued by the European institutions, a
comprehensive list of links with cancer related
Web-sites (to avoid overlapping of information),
etc.
|
|
|
Title
of project
AMÉLIORATION DES
HABITUDES ALIMENTAIRES PAR LE WEB
|
|
|
ORGANISATION
Name: EUROPEAN CANCER PREVENTION ORGANISATION
(ECP)
Address: Rue Martin V/ 40, Bte 5
B-1200 BRUXELLES
Telephone: +32/2/779.06.68
Fax: +32/2/779.06.68
Contact person: Mr. ALAIN MASKENS
|
PARTNER
COUNTRIES
B,I,UK
|
|
START OF
PROJECT: 1/2/99
|
END OF PROJECT:
1/3/00
|
|
COUNTRY OF
ORIGIN: B
|
REFERENCE:
99/CAN/36793
|
|
OBJECTIVE AND
CONTENTS OF THE PROJECT Créer un site WEB
d'information nutritionnelle.
1) diffuser
auprès du grand public les principes d'une
alimentation équilibrée;
2) diffuser les
recommandations nutritionnelles en matière de prévention
du cancer (l'apport en fruits, légumes, céréales;
la consommation en matières grasses);
3) illustrer
par quelques conseils simples comment mettre en
pratique ces recommandations;
4) susciter
chez les consommateurs, la volonté d'approfondir
leurs connaissances en matière de nutrition et de
santé, le but ultime étant de les amener
progressivement à adopter un comportement
alimentaire sain;
5) inviter les
associations professionnelles et NGO à partager
ce site en fournissant des listes de matériel
d'information disponible.
|
|
|
Title
of project
PILOT PROJECT FOR TWO INTERACTIVE GAMES ON
INTERNET FOR EUROPEAN SCHOOLS ON CANCER
PREVENTION
- VIZIUS NIKOTINA 2000 AND
CANCERTRAP - PHASE II
|
|
|
ORGANISATION
Name: ACCADEMIA NAZIONALE DI MEDICINA
Address: Borgo santo Spirito 3
I-00193 ROME
Telephone: +39 10 5458606
Fax: +39 10 5450056
Contact person: Ms. STEFANIA LEDDA
|
PARTNER
COUNTRIES
I,F,E,EL
|
|
START OF
PROJECT: 1/1/99
|
END OF PROJECT:
1/1/00
|
|
COUNTRY OF
ORIGIN: I
|
REFERENCE:
99/CAN/36797
|
|
OBJECTIVE AND
CONTENTS OF THE PROJECT
The project
takes up recommendations of the third action plan
to combat cancer (1996-2000), Decision n°
646/96/EC of the European Parliament and of the
Council of 29 March 1996. The project's aims are :
1) to continue with the circulation of the two
CD-ROM (Vizius Nikotina 2000 and Cancertrap) and
to instigate further competitions both for the
schools who have already participated and those
who want to continue, 2) to supply and distribute
throughout Europe two innovative tools which
interconnects schools in Italy with the rest of
Europe and permits the rapid exchange of data,
experience and above all the supply of useful
information to improve basic health education.
Priority is given to risks factors of cancer,
particularly tobacco, smoking prevention,
nutrition and exposure to the sun. The following
themes will also be addressed : how a tumour
forms, ecology and cancer, mass screening, lung,
colon and breast cancer, 3) to support active
participation of students providing them two
multimedia and interactive tools and directly
involving them in the prevention of cancer, 4) to
extend knowledge, development and use of
multimedia teaching products, 5) to create
awareness in teachers and stimulate the
responsible institutions to improve health
education in schools.
|
|
|
Title
of project
PASSPORT FOR LIFE
|
|
|
ORGANISATION
Name: CANCER SOCIETY OF FINLAND
Address: Liisankatu 21 B
FIN-00170 HELSINKI
Telephone: +358/9/135331
Fax: +358/9/1351093
Contact person: Mr. MERVI PERKINEN
|
PARTNER
COUNTRIES
E,EL,F,FIN
|
|
START OF
PROJECT: 1/1/99
|
END OF PROJECT:
31/12/99
|
|
COUNTRY OF
ORIGIN: FIN
|
REFERENCE:
99/CAN/36816
|
|
OBJECTIVE AND
CONTENTS OF THE PROJECT The aim of the Passport
for Life - project is to : 1) Enhance awareness of
cancer risks among young people all over Europe 2)
Encourage young people to adopt healthy lifestyles
all over Europe
|
|
|
Title
of project
ENYPAT - FRAMEWORK PROJECT
|
|
|
ORGANISATION
Name: NATIONAL PUBLIC HEALTH INSTITUTE (KTL)
Address: 166 Mannerheimintie
FIN-00300 HELSINKI
Telephone: +358.9.47441
Fax: +358.9.4744 8338
Contact person: Mr. ERKKI VARTIAINEN
|
PARTNER
COUNTRIES
A,B,D,DK,E,EL,F,FIN,I,IRL,L,NL,P,S,UK
|
|
START OF
PROJECT: 1/3/99
|
END OF PROJECT:
|
|
COUNTRY OF
ORIGIN: FIN
|
REFERENCE:
99/CAN/36837
|
|
OBJECTIVE AND
CONTENTS OF THE PROJECT
The aim of the
Network is to contribute to the reduction of
tobacco use among young people in Europe by:
- developing,
coordinating and administrating the ENYPAT
Framework project in order to get wider and more
coherent smoking prevention programs at European
level : Smokefree Class Competition, Smoke Free
Partnerships, Retia, Quit and win - Don't start
and win.
- promoting
collaboration between health educators, experts
and researchers.
- gathering and
exchanging information and experiences about
smoking, smoking prevention, smoking cessation
programs and tobacco policy.
|
|
|
Title
of project
ENSP FRAMEWORK PROJECT 1999
|
|
|
ORGANISATION
Name: EUROPEAN NETWORK FOR SMOKING PREVENTION
Address: 48, rue de Pascale
B-1040 BRUSSELS
Telephone: +32/2/230.65.15
Fax: +32/2/230.75.07
Contact person: Mrs. SYBILLE FLEITMANN
|
PARTNER
COUNTRIES
B,A,DK,FIN,F,D,EL,IRL,I,NL,P,E,S,UK
|
|
START OF
PROJECT: 15/9/99
|
END OF PROJECT:
15/6/00
|
|
COUNTRY OF
ORIGIN: B
|
REFERENCE:
99/CAN/36912
|
|
OBJECTIVE AND
CONTENTS OF THE PROJECT
The European
Network for Smoking Prevention has been created
with the specific mission to develop a strategy
for co-ordinated action among organisations active
in tobacco control in Europe by uniting them under
one umbrella network. The aim is to create greater
coherence among smoking prevention projects and to
promote comprehensive tobacco control policies at
national and at European level. The aim is to
COORDINATE NATIONAL PROJECT PROPOSALS INTO A
EUROPEAN FRAMEWORK PROJECT IN ORDER TO PROMOTE
COHERENCE? COST-EFFECTIVENESS AND LARGE
GEOGRAPHICAL COVERAGE TO EAC FUNDED PROJECTS.
|
|
|
Title
of project
CANCER PREVENTION THROUGH WORKPLACE
|
|
|
ORGANISATION
Name: FINNISH INSTITUTE OF OCCUPATIONAL HEALTH
Address: Topeliuksenkatu 41 a A
FIN-00250 HELSINKI
Telephone: +358/9/47471
Fax: +358/9/2414634
Contact person: Dr. TIMO PARTANEN
|
PARTNER
COUNTRIES
FIN,S,D,E
|
|
START OF
PROJECT: 1/1/99
|
END OF PROJECT:
31/12/99
|
|
COUNTRY OF
ORIGIN: FIN
|
REFERENCE:
99/CAN/37090
|
|
OBJECTIVE AND
CONTENTS OF THE PROJECT
This is a
feasibility phase for targeted, evaluated
workplace interventions toward reduction of major
cancer hazards (tobacco, infectious agents,
workplace carcinogens, environmental carcinogens,
radiation, pesticides, alcohol) and promotion of
preventive measures (early detection,
immunoprevention, chemoprevention). The
feasibility phase consists of Workplace Community
Analyses (WCA) in selected branches in Finland,
Sweden, Germany and Spain. The broad content areas
of WCA are cancer data, regulations, needs,
accesses, support, constraints, modes for hazard
reduction, and expected non cancer effects. The
feasibility phase will produce manuscripts of 3
scientific articles, a text for a booklet on how
to conduct wuick WCAs for cancer prevention, and
protocols for extending and editing fact texts and
for pilot testing of the fact text and
interventions.
|
|
|
Title
of project
PILOT CYTOLOGY LABORATORY ORGANISATION FOR
IMPROVED CONSUMER PROTECTION IN CERVICAL
CANCER SCREENING
|
|
|
ORGANISATION
Name: CYTOLOGICAL INSTITUTE OF THE BAVARIAN CANCER
SOCIETY
Address: 14 Prinzregentenplatz
D-81675 MÜNCHEN
Telephone: +49/89/41.94.350
Fax: +49/89/41.40.48.76
Contact person: Dr. ULRICH SCHENCK
|
PARTNER
COUNTRIES
D,B,E,I,NL,UK,IRL,DK,F,EL
|
|
START OF
PROJECT: 1/1/99
|
END OF PROJECT:
1/8/00
|
|
COUNTRY OF
ORIGIN: D
|
REFERENCE:
99/CAN/36663
|
|
OBJECTIVE AND
CONTENTS OF THE PROJECT
This project is
an essential part of the Cervical Cancer Screening
Network and contributes to the further development
of the European Guidelines for Quality Assurance
in Cervical Cancer Screening by :
a) Further
development of the pilot structure of our
laboratory organisation based on continuous
monitoring of the screening scanpass
b) Improved
reporting of cytological findings despite
international diversity as shown by the EQUIVALENT
TERMINOLOGY from the European Guidelines and IAC
TASK FORCE ON TERMINOLOGY, BETHESDA, MUNICH report
schemes.
c) Compiling
data for tables 2, 3, 4, 5 of Appendix A of the
European Guidelines and development of a concept
for restructuring and improvement of the German
screening programme.
|
|
|
Title
of project
RANDOMISED STUDIES OF SCREENING FOR HUMAN
PAPILLOMAVIRUS INFECTION WITHIN ORGANIZED
CERVICAL SCREENING PROGRAMS
|
|
|
ORGANISATION
Name: KAROLINSKA INSTITUTE (MICROBIOLOGY AND TUMOR
BIOLOGY CENTER)
Address: box 280
S-17177 STOCKHOLM
Telephone: +46/8/7286299
Fax: +46/8/326702
Contact person: Prof. JOAKIM DILLNER
|
PARTNER
COUNTRIES
S,NL,FIN,D
|
|
START OF
PROJECT: 1/3/99
|
END OF PROJECT:
31/12/00
|
|
COUNTRY OF
ORIGIN: S
|
REFERENCE:
99/CAN/36731
|
|
OBJECTIVE AND
CONTENTS OF THE PROJECT
To investigate
the feasibility and effectiveness of screening for
Human Papillomavirus (HPV) infection within an
organized cervical cancer screening programme.
As part of the
proposal, we intend to assess 1) the
population-based prevalence of transcient and
persistent HPV infections within an age stratum
where implementation of HPV screening is
conceivable; 2) whether treatment of atypias
detected among HPV-positive women referred to
colposcopy results in a reduced incidence of
high-grade dysplasia in the next organized round
of cytological screening 3 or 5 years later.
|
|
|
Title
of project
EUROPEAN BREAST CANCER SCREENING NETWORK
|
|
|
ORGANISATION
Name: THE CANCER SOCIETY IN STOCKHOLM
Address: Oncologic Centre, Karolinska Hospital
S-171 76 STOCKHOLM
Telephone: +46/8/336800
Fax: +46/8/321700
Contact person: Prof. SVEN TÖRNBERG
|
PARTNER
COUNTRIES
E,B,I,NL,UK,IRL,DK,D,F,EL
|
|
START OF
PROJECT: 1/2/99
|
END OF PROJECT:
1/11/00
|
|
COUNTRY OF
ORIGIN: S
|
REFERENCE:
99/CAN/36750
|
|
OBJECTIVE AND
CONTENTS OF THE PROJECT
The primary aim
of the breast cancer screening network is to
improve the quality of breast cancer screening
service in Europe. The bases for the activities
are described int he document; the European
Guidelines for Quality Assurance in Mammography
Screening. (2nd Edition). The desirable endpoints
for each member of this network is the
establishment of a national breast screening
service in which they operate as service and/or
reference centre. Special attention is given to
service, research and training of personnel
involved in the screening process.
For this
network three arms of activities are identified :
- A) Activities
direct related to the quality of the screening
process : i.e. improvement of compliance, double
reading of mammograms, documentation of
activities, including optimising cancer registry,
monitoring physical quality control, assessment,
surgical follow-up of screen detected lesions.
- B) Supportive
activities : i.e. training, site visits, external
physico technical control and national development
of guidelines and protocols.
- C)
Feasibility studies related to breast cancer
screening : i.e. Cost effectiveness evaluation,
harmonisation of cyto-pathology classification,
psychological aspects of screening.
|
|
|
Title
of project
META-SYNTHESIS OF EUROPEAN
COLORECTAL
CANCER SCREENING TRIALS
|
|
|
ORGANISATION
Name: ACADEMIC HOSPITAL, ERASMUS UNIVERSITY
ROTTERDAM
Address: P.O. Box 1738
NL-3000 DR ROTTERDAM
Telephone: +31/10/4087714
Fax: +31/10/4366831
Contact person: Dr. MARJOLEIN VAN BALLEGOOIJEN
|
PARTNER
COUNTRIES
NL,UK,F,DK,I,NL,S
|
|
START OF
PROJECT: 1/1/99
|
END OF PROJECT:
31/8/00
|
|
COUNTRY OF
ORIGIN: NL
|
REFERENCE:
99/CAN/36898
|
|
OBJECTIVE AND
CONTENTS OF THE PROJECT
Meta-synthesis
of the data of respective European colorectal
cancer (CRC) screening trials (finished and
ongoing) using the biomedical computer simulation
model MISCAN. The aim is to further develop this
evaluation tool for CRC screening in Europe and to
obtain more knowledge of the natural history of
colorectal cancer, the sensivity of the screening
tests and the differences in these aspects between
countries. This knowledge, together with the
original data from the trials, will be used by the
project-group (and be useful for others) to
develop quality assurance guidelines for CRC
screening in Europe, accounting for local
differences.
This project's
aim is in accordance with action 16 of the Third
Action Plan to combat cancer (1996-2000). 1999
Work Programme indicating the priorities for
action' of the European Commission, which states
that The Programme particularly invites proposals
relating to the development of evaluation tools
for colong cancer screening.
|
|
|
Title
of project
PALLIATIVE CARE FOR CANCER PATIENTS IN THE
NORDIC COUNTRIES, ACONSENSUS CONFERENCE
|
|
ORGANISATION
Name: THE NORDIC SCHOOL OF PUBLIC HEALTH
Address: PO Box 12133
S-402 42 GÖTEBORG
Telephone: +46 31 69 39 00
Fax: +46 31 69 17 77
Contact person: Mr. LILIAN AXELSSON |
PARTNER
COUNTRIES
N |
| START
OF PROJECT: 1/2/99 |
END
OF PROJECT: 11/9/99 |
| COUNTRY
OF ORIGIN: S |
REFERENCE:
99/CAN/36363 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
It is our aim to organise a consensus conference
on how to measure and how to improve the quality
of life and quality of death for cancer patients.
The theme of the conference is Live until you die.
The programme includes lectures on palliative care
of cancer patients and lectures on the
psychological, social and ethical aspects of
terminal illness and death. The aim of the
conference is to produce a consensus paper on the
goals of education and training in these aspects
for health personnel in general practice and in
hospitals. This obtained by selecting lecturers
from different medical specialities of doctors and
nurses and from several countries. |
|
|
Title
of project
TRAINING COURSE IN QUALITY OF LIFE
EVALUATION
FOR CANCER PATIENTS
|
|
ORGANISATION
Name: EUROPEAN ORGANISATION FOR RESEARCH &
TREATMENT OF CANCER (EORTC), QUALITY OF LIFE STUDY
GROUP (QLSG)
Address: Dept. of Clinical Psychology, Outpatient
Building Western General Hospital
UK-EH4 2XU EDINBURGH
Telephone: +44/131/537 1836
Fax: +44/131/343 6869
Contact person: Mrs. TERESA YOUNG |
PARTNER
COUNTRIES
B,UK,NL |
| START
OF PROJECT: 1/1/99 |
END
OF PROJECT: 1/3/00 |
| COUNTRY
OF ORIGIN: UK |
REFERENCE:
99/CAN/36507 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
The project aims to train health care
professionals (HCPs) in how to evaluate the
Quality of Life (QL) of cancer patients. The
expertise of the EORTC's QL Study Group (QLSG) and
QL Unit will be used to design and evaluate a
training course accommodating 20-40 persons.
Participants will be able to identify when QL
outcomes should be assessed and select appropriate
QL measures. They will learn how to design and
conduct QL studies, to obtain reliable, valid and
clinically relevant information. The benefits and
problems of cross cultural QL evaluation will be
discussed. This proposal seeks support for course
fees and accommodation for 20 HCPs from EU states
to attend. Priority will be given to those active
in oncology clinical trials, with little or no
experience in QL evaluation, working in EORTC
accredited centres for whom funding is not
available elsewhere. |
|
|
Title
of project
PALLIATIVE CARE IN ONCOLOGY
- A MULTI-PROFESSIONAL APPROACH
|
|
ORGANISATION
Name: EUROPEAN RAMAZZINI FOUNDATION
Address: 18, via Guerrazzi
I-40125 BOLOGNA
Telephone: +39/51/6640143
Fax: +39/51/6640223
Contact person: Dr. MORANDO SOFFRITTI |
PARTNER
COUNTRIES
I,UK,IRL |
| START
OF PROJECT: 8/3/99 |
END
OF PROJECT: 8/4/99 |
| COUNTRY
OF ORIGIN: I |
REFERENCE:
99/CAN/36565 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
a) To educate and empower participants with
specialist palliative medicine skills in symptom
control in advanced cancer.
b) To enable participants to understand how a
broad approach needs to be adopted to deliver high
quality symptom control. By discussing holistic
care, the course participants will see how
physical, emotional, social and spiritual needs
interact and by addressing these, thotal symptom
control can be achieved.
c) To explore and generate interest in team work
and how this can be applied to improve patient
care.
d) To enable participants to appreciate that open
communication with all health care professionals
will lead to a seamless, effective, co-ordinated
care package. |
|
|
Title
of project
PREVENTION OF DEVIATIONS AND ACCIDENTS
THROUGH QUALITY ASSURANCE PROGRAMME FOR
RADIOTHERAPY CENTRES IN EUROPE
|
|
ORGANISATION
Name: NETWORK OF EUROPEAN CENTRES
Address: 49, Herestraat
B-3000 LEUVEN
Telephone: +32/16/34.76.00
Fax: +32/16/34.76.23
Contact person: Dr. DOMINIQUE HUYSKENS |
PARTNER
COUNTRIES
B,NL,F,I,E,P,EL,IRL,S,UK,A,D,DK |
| START
OF PROJECT: 1/1/99 |
END
OF PROJECT: 31/1/00 |
| COUNTRY
OF ORIGIN: B |
REFERENCE:
99/CAN/36652 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
- To develop the methodology for monitoring
quality control procedures in radiotherapy
centres, as well relating to calibration of
equipments as to the procedures used in the whole
process of preparing and administrating
radiotherapy.
- To run pilot tests to assess methodological
feasibility in centres with research expertise
(reference centres of the Network and of the EORTC
Radiotherapy Group).
- To test the monitoring procedures in a large
scale format also including centres without
specialised know-how.
- To transfer the technical knowledge and
guidelines to the ESTRO so that core procedures
and standards can be harmonised in all countries
of the EC. |
|
|
Title
of project
GENETIC EDUCATION AND CANCER PREVENTION IN
EUROPE
|
|
ORGANISATION
Name: EUROPEAN GENETICS FOUNDATION
Address: Via Campodonico, 31/3
I-16030 PIEVE LIGURE (GE)
Telephone: +39/010/3461069
Fax: +39/010/3460362
Contact person: Dr. MARCO SERI |
PARTNER
COUNTRIES
A,B,D,DK,E,EL,F,FIN,I,IRL,L,NL,P,S,UK |
| START
OF PROJECT: 1/5/99 |
END
OF PROJECT: 1/4/00 |
| COUNTRY
OF ORIGIN: I |
REFERENCE:
99/CAN/36671 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
The three main aims of this project are :
- to improve advanced training in genetic for
health professionals (M.D.s and biologists)
already working in the field of cancer prevention,
a field of preventive medicine in which knowledge
of Genetics is indispensable
- to promote the establishment of a new
professional figure for the genetic counselling of
families and patients (genetic associates or
genetic nurses)
- to create an interface for communication with
the general public, using specialized training in
genetics for journalists and science writers.
These aims can be achieved by organizing the two
courses described below (see "Description of
tasks"). |
|
|
Title
of project
EUROPEAN NETWORK OF TEACHING CANCER CARE
IN GENERAL PRACTICE
|
|
ORGANISATION
Name: ACADEMIC MEDICAL CENTER - UNIVERSITY OF
AMSTERDAM
Address: Meibergdreef 15
NL-1105 AZ AMSTERDAM
Telephone: +31/20/566 4696
Fax: +31/20/691 3548
Contact person: Prof. EGBERT SCHADE |
PARTNER
COUNTRIES
A,B,D,DK,E,EL,F,FIN,I,IRL,L,NL,P,S,UK |
| START
OF PROJECT: 1/4/99 |
END
OF PROJECT: 1/7/00 |
| COUNTRY
OF ORIGIN: NL |
REFERENCE:
99/CAN/36681 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
General aim :
To further design, develop and disseminate
teaching and learning methods in cancer care and
control in General Practice, focussing on
prevention, communication skills and palliative
care.
Goals : To:
* To facilitate the development of national
projects;
* foster the development of cancer care in general
practice nationally;
* provide the opportunity to share and exchange
consepts and methods;
* provide a forum for the sharing, exchange and
development of educational ideas and methods as
well as relevant clinical practice;
* develop general practice educators;
* facilitate the development of evaluation methods
for national and international projects;
* promote the cascading of projects nationally;
* disseminate educational programmes for
consideration by other countries;
* provide a forum for the dissemination of ideas,
concepts and methods beyond the cancer field;
* promote the publication of project and network
processes and outcomes through various mediums;
* promote the network within the existing general
practice networks of WONCA and EURACT. |
|
|
Title
of project
EUROPEAN COORDINATED IMPLEMENTATION OF A
NEW MOLECULAR STRATEGY FOR PREVENTION OF
CLINICAL RELAPSE IN LEUKEMIA VIA A
TRAINING AND QUALITY CONTROL PROGRAM
|
|
ORGANISATION
Name: INSTITUT PAOLI-CALMETTES
Address: 232 Bd. Sainte Marguerite
F-13009 MARSEILLE
Telephone: +33/4/91.22.34.47
Fax: +33/4/91.22.35.44
Contact person: Dr. JEAN GABERT |
PARTNER
COUNTRIES
A,B,D,E,F,I,NL,P,S,UK |
| START
OF PROJECT: 1/3/99 |
END
OF PROJECT: 1/10/01 |
| COUNTRY
OF ORIGIN: F |
REFERENCE:
99/CAN/36692 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
1. Training of network members in real-time
quantitative polymerase chain reaction (RQ-PCR)
through exchange of personnel between
participating centers of excellence.
2. Establishment of consensus quality control
programs for technical procedures and logistics of
RQ-PCR analysis.
3. Cost-effectiveness evaluation to assess the
economic impact of the new RQ-PCR diagnostic
procedure.
4. Efficient dissemination of results and
conclusions obtained via the European and national
networks. |
|
|
Title
of project
PSYCHOLOGISCHE UND SOZIALE ASPEKTE
UND LEBENSQUALITÄT VON
BRUSTKREBSPATIENTINNEN.
QUALITÄTSSICHERUNG IN DER
TERTIÄRPRÄVENTION
|
|
ORGANISATION
Name: INSTITUT FÜR INNOVATIVE
GESUNDHEITSKONZEPTE, ISERMANN & DIEGELMANN GBR
Address: Wilhelmshöher Allee 259
D-34131 KASSEL
Telephone: +49/561/35030
Fax: +49/0561/35030
Contact person: Ms. MARGARETE ISERMANN |
PARTNER
COUNTRIES
A,D,E,I,IRL,NL,UK |
| START
OF PROJECT: 15/3/99 |
END
OF PROJECT: 1/3/00 |
| COUNTRY
OF ORIGIN: D |
REFERENCE:
99/CAN/36699 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
It is planned to develop a practical instrument to
measure the quality of life, including
psychological and social aspects, of breast cancer
patients. In so doing, specifically female
experiences in various European countries and
findings of research into women's health will be
considered. This instrument is to take the form of
an easily-interpreted profile for use in routine
health care. It will enable both doctors providing
treatment as well as other professional groups
with no special training in psychodiagnostics to
gain an overall view of the patient's individual
situation and to detect any accomanying
psychopathological symptoms at an early stage. A
longer-term aim is to introduce a valid and
practical procedure in oncological settings as a
contribution to tertiary prevention and palliative
care that will improve quality assurance in terms
of systematic outcome management. |
|
|
Title
of project
MODELOS DE CUIDADOS PALIATIVOS EN
PACIENTES CON CÁNCER Y SU INFLUENCIA EN
LA CALIDAD DE VIDA :
RED EUROPEA DE INVESTIGACIÓN E
INTERCAMBIO
|
|
ORGANISATION
Name: ESCUELA ANDALUZA DE SALUD PUBLICA
Address: Campus Universitario Cartuja - Apdo. 2070
E-18080 GRANADA
Telephone: (+34) 58 16 10 44
Fax: (+34) 58 16 11 42
Contact person: Ms. MA ANGELES PRIETO-RODRÍGUEZ |
PARTNER
COUNTRIES
E,I,P |
| START
OF PROJECT: 1/4/99 |
END
OF PROJECT: 1/4/00 |
| COUNTRY
OF ORIGIN: E |
REFERENCE:
99/CAN/36895 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
A. To describe the various palliative (hospital
and home) care models for cancer which are being
used in various countries of the European Union.
B. To determine the quality of life of cancer
patients who require palliative care in each
country by means of the various instruments used
currently in the EU for this purpose. This will be
used as a basis for validating and adapting a
Europe-wide questionnaire which will enable
internationally comparable data on the European
Union countries to be obtained in the future.
C. To analyse and compare the impact on quality of
life of the various types of palliative care for
cancer, both in hospitals and at home.
D. To analyse European vocational training
programmes for palliative care for patients with
tumours, identifying existing weaknesses and
proposing an agreed curriculum for the
undergraduate and post-graduate training of
social/health professionals based on the
experience acquired and results obtained under
aims A and B.
E. To prepare the ground for a European network of
researchers and professionals who are engaged in
palliative care for patients suffering from
tumours with the aim of promoting a permanent
forum for communications, exchange and information
between groups and for bibliographical material
which will help form a fuller picture of this
subject. |
|
|
Title
of project
PREVENTION MANAGEMENT TOOLS FÜR
ARBEITSMEDIZINERINNEN - KREBSERZEUGENDE
ARBEITSSTOFFE IM BETRIEB
|
|
ORGANISATION
Name: PPM FORSCHUNG UND BERATUNG - ARBEIT,
GESUNDHEIT, UMWELT
Address: Kaplanhofstraße 1
A-4020 LINZ
Telephone: +43/732/78.20.78-0
Fax: +43/732/78.20.78-99
Contact person: Mr. GERHARD ELSIGAN |
PARTNER
COUNTRIES
A |
| START
OF PROJECT: 1/4/99 |
END
OF PROJECT: 30/11/00 |
| COUNTRY
OF ORIGIN: A |
REFERENCE:
99/CAN/37014 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
To enhance occupational physician's skills in
terms of prevention, intervention and advice at
work. This aim is to be achieved in particular by:
* Surveying and documenting teaching syllabuses
and methods used in European training courses on
carcinogenic substances for occupational
physicians;
* Surveying, documenting and exchanging methods,
instruments and innovative measures in training
courses for occupational physicians in order to
equip them to devise and implement preventive
measures in their enterprises (prevention
management tools);
* Developing and conducting pilot training modules
on carcinogenic substances for occupational
physicians and exchanging notes on pilot training
modules in the participating countries (A,D,NL);
* Producing a manual entitled "Prevention
Management tools - carcinogenic substances"
for training occupation physicians. |
|
|
Title
of project
TRAINING HEALTH PERSONNEL IN THE FIELD OF
CANCER : FELLOWSHIPS FOR EUROPEAN HEALTH
PROFESSIONALS WITH TEACHING RESPONSIBILITY
TO IMPROVE THEIR THEORETICAL AND PRATICAL
KNOWLEDGE OF CANCER
|
|
ORGANISATION
Name: EUROPEAN SCHOOL OF ONCOLOGY
Address: V.le Beatrice D'Este, 37
I-20122 MILANO
Telephone: +39/2/58317850
Fax: +39/2/58321266
Contact person: Mr. UGO ROCK |
PARTNER
COUNTRIES
A,B,D,DK,E,EL,F,FIN,I,IRL,L,NL,P,S,UK |
| START
OF PROJECT: 1/1/99 |
END
OF PROJECT: 1/2/00 |
| COUNTRY
OF ORIGIN: I |
REFERENCE:
99/CAN/37073 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
The project aims at contributing to the
implementation of action 17 and 18 of the Europe
Against Cancer Programme of the Third Action Plan
(Officiel Journal of the European Communities,
10/04/96, N° L 95/15), namely to improve the
theoretical and practical knowledge of cancer of
the European health professionals, to support
their mobility among the Member States, to
increase their teaching skills and the consequent
transfer to knowledge and information to their
colleagues at national levels, and to offer the
possibility to attend ESO courses to 40 doctors
from all Member States of the European Union. They
will be selected on the basis of their merits and
of their involvement at a national level in the
training of other health professionals in
prevention, screening, diagnosis and treatment of
cancer. |
|
|
Title
of project
START (STATE OF THE ART IN ONCOLOGY), AN
INDEPENDENT DATABASE FREELY ACCESSIBLE ON
THE INTERNET :
IMPLEMENTATION OF A SYSTEMATIC FEEDBACK
PROCESS
FROM THE EUROPEAN ONCOLOGICAL COMMUNITY
|
|
ORGANISATION
Name: EUROPEAN SCHOOL OF ONCOLOGY
Address: V.le Beatrice D'Este, 37
I-20122 MILANO
Telephone: +39/2/58317850
Fax: +39/2/58321266
Contact person: Mr. UGO ROCK |
PARTNER
COUNTRIES
I,UK,DK,B,D |
| START
OF PROJECT: 1/2/99 |
END
OF PROJECT: 1/3/00 |
| COUNTRY
OF ORIGIN: I |
REFERENCE:
99/CAN/37110 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
This project aims at further implementing the
feedback process on the content of START (State of
the Art Oncology in Europe). In the light of the
preliminary results of the previous pilot project.
It is felt taht the feedback process should be
mainly based on the European cancer societies.
This will allow to extend the feedback mechanism
to the full text of each chapter (the pilot
project focused only on selected statements of the
chapters), and, in a formal fashion, to all the
codified statements which will be felt to be most
questionable and/or relevant (in the pilot project
this selection had been made by the START
editorial board). In addition, this new project
will cover all the chapters available on the
Internet by the end of 1998. Thus the aim of this
new project is to verify the feasibility of a more
comprehensive feedback mechanism on the START
chapters, which could constitute the definitive
pattern for the START feedback process from the
year 2000 onwards. A permanent feedback process is
felt to be a major requisite for START to be a
true state-of-the-art European instrument. |
|
|
Title
of project
REDUCTION OF RADIATION MORBIDITY
THROUGH
QUALITY ASSURANCE DOSIMETRY AND EVALUATION
OF MORBIDITY
|
|
ORGANISATION
Name: EUROPEAN SOCIETY FOR THERAPEUTIC RADIOLOGY
AND ONCOLOGY (ESTRO)
Address: Av. E. Mounierlaan, 83/4
B-1200 BRUSSELS
Telephone: +32/2/7759340
Fax: +32/2/7795494
Contact person: Prof. WILFRIED DE NEVE |
PARTNER
COUNTRIES
B,E,I,D,FIN,F,NL,S,UK |
| START
OF PROJECT: 1/4/99 |
END
OF PROJECT: 1/6/01 |
| COUNTRY
OF ORIGIN: B |
REFERENCE:
99/CAN/37160 |
OBJECTIVE
AND CONTENTS OF THE PROJECT
The aim is to reduce the morbidity after
radiotherapy but at the same time preserving or
increasing the probability of local control of the
tumour. Most radiotherapy related morbidity is
caused by unintended delivery of dose to healthy
tissues above the known levels of tolerance. The
prescription itself as well as any process or tool
involved in the preparation and delivery of
raidotherapy may carry (hidden) elements that may
lead to exceeding tolerance doses. The first task
is to improve dosimetry as small deviations in the
dose might result in adverse effects. The
methodology developed in the EC network project
will be followed. The second task is to assess the
present situation regarding morbidity in order to
be able to estimate the efficiency of the various
treatment regimes. Combination of task 1 with task
2 allows to exclude significant dose deviations as
a possible cause of complications. |
|
| |
